Voyager Therapeutics, Inc.

VYGR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$45,125$43,940$74,755$71,367
Short-Term Investments$163,805$171,653$161,264$195,317
Receivables$4,037$2,525$2,110$4,491
Inventory$0$0$0$0
Other Curr. Assets$6,618$9,771$7,077$5,634
Total Curr. Assets$219,585$227,889$245,206$276,809
Property Plant & Equip (Net)$43,031$44,892$46,057$47,663
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$20,081$46,446$59,103$65,704
Tax Assets$0$0$0$0
Other NC Assets$5,614$2,874$2,874$2,874
Total NC Assets$68,726$94,212$108,034$116,241
Other Assets$0$0$0$0
Total Assets$288,311$322,101$353,240$393,050
Liabilities
Payables$2,116$1,804$2,634$3,996
Short-Term Debt$7,848$7,637$7,430$7,227
Tax Payable$0$0$0$0
Deferred Revenue$0$0$21,095$24,394
Other Curr. Liab.$25,531$32,542$9,053$14,171
Total Curr. Liab.$35,495$41,983$40,212$49,788
LT Debt$30,520$32,567$34,566$36,499
Deferred Rev, NC$0$0$4,760$6,003
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,471$3,607$1,000$1,000
Total NC Liab.$32,991$36,174$40,326$43,502
Other Liabilities$0$0$0$0
Cap. Leases$38,368$40,204$41,996$43,726
Total Liabilities$68,486$78,157$80,538$93,290
Equity
Pref Stock$0$0$0$0
Common Stock$56$56$55$55
Retained Earnings-$418,479-$390,587-$357,205-$326,184
AOCI$7-$221-$199-$407
Other Equity$638,241$634,696$630,051$626,296
Total Equity$219,825$243,944$272,702$299,760
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$288,311$322,101$353,240$393,050
Net Debt-$6,757-$3,736-$32,759-$27,641
Voyager Therapeutics, Inc. (VYGR) Financial Statements & Key Stats | AlphaPilot